No image
Inquiry Submitted Successfully


  • Product Name : Brimonidine
  • Grade : IP / BP / USP
  • Therapeutic Category : Antiglaucoma
  • CAS No : 70359-46-5
  • Other Name : Brimonidine Tartrate
  • COA : Available
  • MSDS : Available


Brimonidine is a drug used to treat open-angle glaucoma or ocular hypertension, and as a gel, Mirvaso, for facial skin redness in rosacea.



White to slightly yellowish powder 


Soluble in water, slightly souluble in methanol





Melting point-


Specific rotation-

 +  9.0° ~  +  10.5°

Loss on drying-


Residue on ignition-

≤ 0.1%

Heavy metals-

≤10 ppm

Related substances-

Single impurity ≤0.2%

Total impurities ≤0.5%



Total  aerobic microbial count-

Total bacterial count <100cfu/gr

Total fungal<10cfu/gr


Packaging details:


Packaging details:

25kg/drum with double plastic bags inside; packed in a cardboard drum or fiber HDPE drum.


Stored in a clean, cool, dry area; keep away from moisture and strong, direct light/heat

Shelf Life:

5 years if sealed and store away from direct sun light.

Additional Information

The most common markets for this product include the following countries. Please inquire with us if your country or region is not listed:

Asia: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

North & South America: USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela , Brazil, Bahamas, Ecuador, etc .

Europe: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, etc.

OCEANIA: Australia, New Zealand, Fiji, etc.